Oppenheimer Maintains Outperform on CME Gr, Raises Price Target to $245

Benzinga · 10/14 15:33
Oppenheimer analyst Owen Lau maintains CME Gr (NASDAQ:CME) with a Outperform and raises the price target from $228 to $245.